FibroBiologics, Inc. (FBLG) SEC Filings https://ir.fibrobiologics.com/sec-filings/all-sec-filings/rss FibroBiologics, Inc. (FBLG) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_14a954ff2903678ce9699bf59a0e1fd9/fibrobiologics/files/theme/images/logo-sm.png FibroBiologics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[8-K - Current report]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-395511/0001193125-26-395511.pdf Fri, 18 Sep 26 16:06:30 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-395511/0001193125-26-395511.pdf <![CDATA[SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-043112/0001493152-26-043112.pdf Thu, 17 Sep 26 16:02:33 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-043112/0001493152-26-043112.pdf <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-042792/0001493152-26-042792.pdf Wed, 16 Sep 26 06:01:59 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-042792/0001493152-26-042792.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-042794/0001493152-26-042794.pdf Tue, 15 Sep 26 19:27:55 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-042794/0001493152-26-042794.pdf <![CDATA[8-K - Current report]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-391310/0001193125-26-391310.pdf Tue, 15 Sep 26 07:15:47 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-391310/0001193125-26-391310.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-386485/0001193125-26-386485.pdf Wed, 09 Sep 26 16:21:03 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-386485/0001193125-26-386485.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-041112/0001493152-26-041112.pdf Tue, 01 Sep 26 19:18:22 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001493152-26-041112/0001493152-26-041112.pdf <![CDATA[8-K - Current report]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-362027/0001193125-26-362027.pdf Mon, 24 Aug 26 08:48:46 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-362027/0001193125-26-362027.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001172661-26-003577/0001172661-26-003577.pdf Fri, 14 Aug 26 10:13:44 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001172661-26-003577/0001172661-26-003577.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-328454/0001193125-26-328454.pdf Fri, 31 Jul 26 16:04:40 -0400 https://ir.fibrobiologics.com/sec-filings/all-sec-filings/content/0001193125-26-328454/0001193125-26-328454.pdf